Dow Jones Newswires

BioCryst Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

6/30/2026, 10:45 PM GMT+8 Dow Jones Newswires

(14:45 GMT) BioCryst Pharmaceuticals Price Target Maintained With a $32.00/Share by HC Wainwright & Co.